Publications Database

Early M. C. et al. (2012)

Case report: 16-year-old male with autistic disorder with preoccupation with female feet.

Journal of Autism and Developmental Disorders

May, 42(6), pp. 1133-1137.

Read Abstract (New Window)

Erickson C. A. et al. (2011)

A prospective open-label study of aripiprazole in fragile X syndrome.

Psychopharmacology (Berl)

July, 216(1), pp. 85-90.

Read Abstract (New Window)

Erickson C. A. et al. (2011)

A prospective open-label study of aripiprazole in fragile X syndrome.

Psychopharmacology (Berl)

July, 216(1), pp. 85-89.

Read Abstract (New Window)

Erickson C. A. et al. (2011)

An open-label naturalistic pilot study of acamprosate in youth with autistic disorder

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Erickson C. A. et al. (2014)

Brief report: Pilot single-blind placebo lead-in study of acamprosate in youth with autistic disorder.

Journal of Autism and Developmental Disorders

April, 44(4), pp. 981-987.

Read Abstract (New Window)

Erickson C. A. et al. (2013)

Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.

Psychopharmacology (Berl)

July, 228(1), pp. 75-78.

Read Abstract (New Window)

Fitzpatrick S. E. et al. (2016)

Aggression in autism spectrum disorder: presentation and treatment options.

Neuropsychiatric Disease and Treatment

2016(12), pp. 1525-1538

Read Abstract (New Window) Read Full (New Window)

Kowalski J. et al. (2011)

Paliperidone palmitate in a child with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

October, 21(5), pp. 491-493

McGuire K. et al. (2015)

Psychiatric hospitalization of children with autism or intellectual disability: Consensus statements on best practices.

Journal of the American Academy of Child and Adolescent Psychiatry

December, 54(12), pp. 969-971.

Read Abstract (New Window)

Minshawi N. F. et al. (2016)

A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders.

Molecular Autism

7(2),

Read Full (New Window)

Orsagh-Yentis D. K. et al. (2011)

Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Vasa R. A. et al. (2014)

A systematic review of treatments for anxiety in youth with autism spectrum disorders.

Journal of Autism and Developmental Disorders

December, 44(12), pp. 3215-3229.

Read Abstract (New Window)

Wink L. K. et al.

A randomized placebo-controlled cross-over pilot study of riluzole for drug-refractory irritability in autism spectrum disorder.

Journal of Autism and Developmental Disorders

Read Abstract (New Window)

Wink L. K. et al. (2016)

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.

Molecular Autism

7(26),

Read Full (New Window)

Wink L. K. et al. (2017)

Brief report: Metformin for antipsychotic-induced weight gain in youth with autism spectrum disorder.

Journal of Autism and Developmental Disorders

July, 47(7), pp. 2290–2294.

Read Abstract (New Window)

Wink L. K. et al. (2017)

d-Cycloserine enhances durability of social skills training in autism spectrum disorder.

Molecular Autism

Read Abstract (New Window) Read Full (New Window)

Wink L. K. et al. (2010)

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Expert Opinion on Emerging Drugs

September, 15(3), pp. 481-494

Read Abstract (New Window)

Wink L. K. , Erickson C. A. , McDougle C. J. (2010)

Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders.

Current Treatment Options in Neurology

12(6), pp. 529-538.

Read Abstract (New Window)